Iyer RK et al (2009) Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering. Rai R et al (2013) Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application. Tallawi M et al (2015) Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. Cell Stem Cell 15(6):750–761Ībbasian M et al (2019) Scaffolding polymeric biomaterials: are naturally occurring biological macromolecules more appropriate for tissue engineering? Int J Biol Macromol 134:673–694 Ye L et al (2014) Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. J Tissue Eng Regen Med 10(1):11–28Ĭhachques JC et al (2007) Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM Clinical Trial): one year follow-up. Reis LA et al (2016) Biomaterials in myocardial tissue engineering. Radisic M et al (2006) Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. J Cell Mol Med 22(6):2964–2969Įlomaa L, Yang YP (2017) Additive manufacturing of vascular grafts and vascularized tissue constructs.
Moldovan NI (2018) Progress in scaffold-free bioprinting for cardiovascular medicine.
Noguchi R et al (2016) Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart disease. Ong CS et al (2017b) Tissue engineered vascular grafts: current state of the field.
Giannopoulos AA et al (2016) Applications of 3D printing in cardiovascular diseases. Benjamin EJ et al (2019) Heart disease and stroke statistics 2019 update: a report from the American Heart Association.